In-Situ Forming Gel with LNG (UTHSC)

Description: Researchers at the University of Tennessee Health Science Center are developing an in situ forming gel that can achieve 6 months of controlled delivery of LNG.

Product Details

User: Female

Hormonal: Yes

Delivery Method: Injectable

Duration Type: Short-acting

Duration: 6 months

  • single injection

Active Pharmaceutical Ingredient (API):
  • levonorgestrel

Inactive material: PLA; PLGA

Multipurpose Preventive Technology (MPT): No

Status Details

Developer: University of Tennessee Health Sciences Center

Project Phase: Pre-Clinical and Clinical Development

Development Stage: Pre-clinical

Began discovery in: 2013

Active Development: Yes

Additional Information


Vertical Tabs